EVH (Evolent Health) Growth Rank: 8 (As of Aug. 20, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EVH Evolent Health Inc EVH
67 GF Score
Price $4.71
GF Value $10.05
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Evolent Health Growth Rank?

Evolent Health EVH +2.73% 67 Growth Rank is 8 as of Aug. 20, 2026, which is at its 10-year median of 8.00. GuruFocus rates EVH with a GF Score™ of 67/100 and a GF Value™ of $10.05 (Possible Value Trap). The stock has 6 warning signs investors should review.

Evolent Health has the Growth Rank of 8.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Evolent Health Growth Rank Related Terms

EVH vs NRC, SOPH, WEAV: Growth Rank Comparison

For the Health Information Services subindustry, Evolent Health's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evolent Health Growth Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's Growth Rank distribution charts can be found below:

* The bar in red indicates where Evolent Health's Growth Rank falls into.


EVH
67GF Score
Evolent Health Inc EVH
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 8 mean?
Evolent Health (EVH) has a Growth Rank of 8 as of Aug. 20, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Evolent Health and its competitors. This is near median its historical median of 8.00. Over the past decade, Evolent Health's Growth Rank has ranged from 3.00 to 9.00.
Is Evolent Health's Growth Rank too high?
Evolent Health's current Growth Rank of 8 is near median its 10-year median of 8.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 9.00. Overall, Evolent Health has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Evolent Health's Growth Rank compare to NRC and SOPH?
Evolent Health's Growth Rank of 8 can be compared against companies in the Healthcare Providers & Services industry. Historically, Evolent Health's own Growth Rank has ranged from 3.00 to 9.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Providers & Services company?
A good Growth Rank depends on the Healthcare Providers & Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Evolent Health and its competitors. Evolent Health's current Growth Rank is 8, which is near median its own 10-year median of 8.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evolent Health stock overvalued right now?
Based on GuruFocus' analysis, Evolent Health (EVH) is currently considered Possible Value Trap. The stock's GF Value™ is $10.05, compared to a current price of $4.71 — trading 53.2% below its estimated fair value. The current Growth Rank is 8, which is near median its 10-year median of 8.00. Evolent Health's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Evolent Health (EVH), the current Growth Rank is 8 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Evolent Health (EVH) Overvalued in 2026?

Based on GuruFocus' analysis, Evolent Health stock appears to be undervalued. The current stock price of $4.71 is trading 53.2% below its estimated GF Value™ of $10.05. GuruFocus considers Evolent Health to be Possible Value Trap.

Key valuation signals for EVH:

  • Growth Rank: 8 (near median its 10-year median of 8.00)
  • GF Value™: $10.05 vs. price of $4.71 (53.2% below fair value)
  • GF Score™: 67/100 with 6 warning signs

No single metric tells the full story. See the EVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Evolent Health Business Description

Other Exchanges 9EH:Germany
Address 1812 North Moore Street, Suite 1705, Arlington, VA, USA, 22209
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
67GF Score

Get the complete analysis for EVH

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.71
Price
$10.05
GF Value